ASXL1 gene alterations in patients with isolated 20q deletion
| Autor: | Kyra Michalova, Jana Markova, Karla Svobodova, Lucie Hodanova, Anna Jonasova, Libuse Lizcova, Karolina Skipalova, Jaroslav Cermak, S Ransdorfova, I Sarova, Silvia Izakova, Jana Brezinova, Lenka Pavlistova, Zuzana Zemanova, Halka Lhotska |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Cancer Research
Myeloid ASXL1 gene business.industry Breakpoint Zinc finger homeobox 2 Chromosomes Human Pair 20 Repressor Proteins 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Myelodysplastic Syndromes Cohort Cytogenetic Analysis medicine Cancer research Humans In patient Abnormality Chromosome Deletion business Gene |
| Zdroj: | Neoplasma. 66(4) |
| ISSN: | 0028-2685 |
| Popis: | Deletion 20q is a recurrent abnormality in myeloid malignancies. In our previous study, we identified fusion of the additional sex combs-like 1 (ASXL1) and teashirt zinc finger homeobox 2 genes in a patient with myelodysplastic syndrome. The objective of this study was to determine the frequency of ASXL1 breakpoints in a cohort of 36 patients with deletion 20q as the sole cytogenetic aberration. A combination of molecular cytogenetic methods was used to confirm ASXL1 gene alterations in 19 of the 36 patients, and the determination of ASXL1 gene changes in patients with deletion 20q revealed clinical and prognostic impacts. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|